Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries

Circulation. 1996 Feb 1;93(3):423-30. doi: 10.1161/01.cir.93.3.423.

Abstract

Background: The use of stents improves the result after balloon coronary angioplasty. Thrombogenicity of stents is, however, a concern. In the present study, we compared stents with an antithrombotic coating with regular stents.

Methods and results: Regular stents were placed in coronary arteries of pigs receiving no aspirin (group 1; n = 8) or aspirin over 4 weeks (group 2, n = 10) or 12 weeks (group 3, n = 9). Stents coated with heparin (antithrombin III uptake, 5 pmol/stent) were placed in 7 pigs that did not receive aspirin (group 4). The other animals received aspirin and coated stents with a heparin activity of 12 pmol antithrombin III/stent (group 5, n = 10) or 20 pmol/stent (group 6, n = 10; group 7, n = 10). Quantitative arteriography was performed at implantation and after 4 (groups 1, 2, and 4 through 6) or 12 weeks (groups 3 and 7). In an additional 5 animals, five regular and five coated stents (20 pmol/stent) were placed and explanted after 5 days for examination of the early responses to the implants. Thrombotic occlusion of the regular stent occurred in 9 of 27 in groups 1 through 3. However, in 0 of 30 of the animals receiving high-activity heparin-coated stents (groups 5 through 7), thrombotic stent occlusion was observed (P < .001). Histological analysis at 4 weeks showed that the neointima in group 6 was thicker compared with its control group 2 (259 +/- 104 and 117 +/- 36 microns, P < .01), but at 12 weeks the thickness was similar (152 +/- 61 and 198 +/- 49 microns, respectively). Comparison at 5 days suggested delayed endothelialization of the coating.

Conclusions: High-activity heparin coating of stents eliminates subacute thrombosis in porcine coronary arteries.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioplasty, Balloon, Coronary
  • Animals
  • Aspirin / administration & dosage
  • Coronary Angiography
  • Coronary Thrombosis / prevention & control*
  • Coronary Vessels* / pathology
  • Equipment Design
  • Follow-Up Studies
  • Heparin / administration & dosage*
  • Hyperplasia
  • Stents*
  • Swine
  • Tunica Intima / pathology

Substances

  • Heparin
  • Aspirin